← Back
▼ SELL

$ Value

$3.3M

Shares

14,372

Price

$227

Filed

Dec 16

Insider

Name

ROSENMAN HERM

Title

CIK

0001230057

Roles

Director

Transaction Details

Transaction Date

2025-12-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

54,389

Footnotes

Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.9450 to $226.9350 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.95 to $227.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.00 to $228.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001230057-25-000005

Form Type

4

Issuer CIK

0001604821

ROSENMAN HERM's History

Date Ticker Type Value
2026-01-30 NTRA A
2025-12-12 NTRA $3.3M
2025-12-12 NTRA $5.0M
2025-12-12 NTRA $2.7M
2025-12-12 NTRA $34K
2025-10-31 NTRA A
2025-07-25 NTRA A
2025-06-27 NTRA A
2025-06-27 NTRA A
2025-04-25 NTRA A

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E $23K 2026-03-13
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.4M 2026-03-10